DNA Script Wins ARPA-H Award to Advance DNA Manufacturing
DNA Script says the company is contributing its EDS technology and acting as a technical solution integrator for the project, while adapting its solution to incorporate GE HealthCare’s proprietary DNA scaling technology. The post DNA Script Wins ARPA-H Award to Advance DNA Manufacturing appeared first on GEN - Genetic Engineering and Biotechnology News .
DNA Script and GE HealthCare have secured a $26 million, four-year funding award from ARPA-H to advance their collaborative FLASH program. FLASH aims to develop a scalable, automated platform for the rapid and distributed production of high-fidelity DNA. This will support research and potential future applications in personalized medicine, vaccines, and genetic health technologies.
DNA Script's enzymatic DNA synthesis (EDS) technology forms the foundation of this initiative, which will be integrated with GE HealthCare's proprietary DNA scaling technology. Together, these innovations aim to bring on-demand manufacturing closer to patient care for next-generation therapies and personalized vaccines. ARPA-H program manager John Schiel emphasizes the bold, practical nature of ARPA-H solutions, while DNA Script CEO Marc Montserrat highlights the suitability of EDS for the on-demand manufacturing model.
GE HealthCare's John Nelson underscores the urgency of faster, more flexible manufacturing approaches for genetic medicines as personalized therapies continue to advance.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
